Abstract
Changes in glycosylation, which is one of the most common protein post-translational modifications, are considered to be a hallmark of cancer. N-glycans can modulate cell migration, cell-cell adhesion, cell signaling, growth and metastasis. The colorectal cancer (CRC) is a leading cause of cancer-related mortality and the correlation between CRC progression and changes in the pattern of expression of N-glycans is being considered in the search for new biomarkers. Here, we review the role of N-glycans in CRC cell biology. The perspectives on emerging N-glycan-related anticancer therapies, along with new insights and challenges, are also discussed.
Author supplied keywords
Cite
CITATION STYLE
De Freitas-Junior, J. C. M., & Morgado-Díaz, J. A. (2016, April 12). The role of N-glycans in colorectal cancer progression: Potential biomarkers and therapeutic applications. Oncotarget. Impact Journals LLC. https://doi.org/10.18632/oncotarget.6283
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.